Quantum-KI-Sturm:
Die größte Bedrohung für Hightech – Milliarden-Chance für Anleger!
Anzeige

BICO - The Bio Convergence Company WKN: A2PX00 ISIN: SE0013647385 Forum: Aktien User: KeXStarQ

2,932 EUR
-0,98 %-0,029
28. Nov, 17:05:12 Uhr, Baader Bank
Kommentare 558
bull01
bull01, 14.09.2023 17:03 Uhr
0
Mehr Verlust als Umsatz/Gewinn. Am besten umschichten bei der nächsten Gelegenheit um Risiko abzuwägen. Einsteigen geht immer sehr schnell. Das jedenfalls werde ich tun.
tragflechentoni
tragflechentoni, 14.09.2023 15:48 Uhr
0
Was schon wieder los hier mit der Aktie
bull01
bull01, 12.09.2023 18:16 Uhr
0
Junge Junge Junge..
T
Teamplayer, 22.08.2023 17:17 Uhr
0
Ich würde ja sogar inzwischen short gehen, finde aber diese Funktion in meiner banking app nicht...
T
Teamplayer, 22.08.2023 17:15 Uhr
0
Finde vom heutigen tag keinerlei Infos die mich positiv stimmen lassen. Vielleicht kann mich jemand aufklären... also was Umsatz, Gewinn, Kosten, ... betrifft. Sehr komisch alles.
a
aniqahmed92, 21.08.2023 22:22 Uhr
0

Danke fürs posten.

Gerne
S
Sz38, 21.08.2023 20:08 Uhr
0
Eine neue CEO bringt das ganze vielleicht auf den richtigen Weg. Mal schauen wo Bico in 2 Jahren steht.
tragflechentoni
tragflechentoni, 21.08.2023 19:58 Uhr
0
😵‍💫
S
Sz38, 21.08.2023 19:56 Uhr
0

Woher die Info ?

Bico.com\investors
S
Sz38, 21.08.2023 19:55 Uhr
1

BICO Group AB (publ) announces that Erik Gatenholm, after initiating discussions with the Board of Directors, has decided to step down as President and CEO of BICO Group. Maria Forss has been appointed new President and CEO. Maria Forss will assume office on November 27, 2023, or sooner. Maria Forss has been appointed new President and CEO and will assume office on November 27, 2023, or sooner. Maria Forss (born 1972) has extensive international experience from leading positions in both medtech and pharma companies, such as Vitrolife and AstraZeneca. The last years within Vitrolife Maria Forss has as the Senior Vice President led the Consumables Business Area and before that she was the Vice President of Business Development and Global Marketing. Maria Forss has successfully developed businesses through the whole value chain and in the whole product life cycle as well as acquisitions and integration of companies. The Board of Directors has, together with Erik Gatenholm, concluded that the timing is right for a new CEO and President. This discussion was initiated by Erik Gatenholm, and he has together with the board concluded that in the next phase BICO needs a CEO with strong operating skills and experience in scaling a global organization. “On behalf of the Board of Directors, I would like to welcome Maria Forss. She has profound leadership skills and life science experience, which will secure steadfast focus during BICO’s further development and create shareholder value”, says Rolf Classon, Chairman of the Board, BICO Group AB. “I would also like to thank Erik Gatenholm for his vision and dedication to build a strong life science company. During his tenure the company has evolved into a Group which is built on a market leading commercial portfolio.” In order to enable a seamless transition, Erik Gatenholm will remain in his current position until Maria Forss assumes as new President and CEO. To secure continuity Erik Gatenholm will, as major shareholder, also remain in his role as board member of BICO. ..

Danke fürs posten.
tragflechentoni
tragflechentoni, 21.08.2023 19:51 Uhr
0
Woher die Info ?
a
aniqahmed92, 21.08.2023 19:48 Uhr
0
Und noch eine schlechte Nachricht ziele für 2024 ubd 2023 nicht erreichbar un d Wertminderung
tragflechentoni
tragflechentoni, 21.08.2023 19:46 Uhr
0
Was hier los 🫣
a
aniqahmed92, 21.08.2023 18:52 Uhr
0
Gatenholm tritt zurück
a
aniqahmed92, 21.08.2023 18:52 Uhr
0
BICO Group AB (publ) announces that Erik Gatenholm, after initiating discussions with the Board of Directors, has decided to step down as President and CEO of BICO Group. Maria Forss has been appointed new President and CEO. Maria Forss will assume office on November 27, 2023, or sooner. Maria Forss has been appointed new President and CEO and will assume office on November 27, 2023, or sooner. Maria Forss (born 1972) has extensive international experience from leading positions in both medtech and pharma companies, such as Vitrolife and AstraZeneca. The last years within Vitrolife Maria Forss has as the Senior Vice President led the Consumables Business Area and before that she was the Vice President of Business Development and Global Marketing. Maria Forss has successfully developed businesses through the whole value chain and in the whole product life cycle as well as acquisitions and integration of companies. The Board of Directors has, together with Erik Gatenholm, concluded that the timing is right for a new CEO and President. This discussion was initiated by Erik Gatenholm, and he has together with the board concluded that in the next phase BICO needs a CEO with strong operating skills and experience in scaling a global organization. “On behalf of the Board of Directors, I would like to welcome Maria Forss. She has profound leadership skills and life science experience, which will secure steadfast focus during BICO’s further development and create shareholder value”, says Rolf Classon, Chairman of the Board, BICO Group AB. “I would also like to thank Erik Gatenholm for his vision and dedication to build a strong life science company. During his tenure the company has evolved into a Group which is built on a market leading commercial portfolio.” In order to enable a seamless transition, Erik Gatenholm will remain in his current position until Maria Forss assumes as new President and CEO. To secure continuity Erik Gatenholm will, as major shareholder, also remain in his role as board member of BICO. ..
S
Schmonti, 21.08.2023 18:25 Uhr
1

Sorry aber du bist wohl echt nicht informiert, letztes Quartal operativ 60 Mio sek an free Cashflow und durch den Gebäude verkauft kommen jetzt nochmal 200 mio sek dazu. Und wenn etwas erwartet wird, kann es nicht negativ überraschen

Danke.
Mehr zu diesem Wert
Thema
1 Diskussion zur BICO Group Aktie
2 BICO - The Bio Convergence Company
3 Cellink - Printing life
Meistdiskutiert
Thema
1 ATOS Hauptdiskussion -41,17 %
2 Europlasma Hauptdiskussion -43,05 %
3 HUGO BOSS Hauptdiskussion -8,67 %
4 TUI Hauptforum +1,96 %
5 GAMESTOP Hauptdiskussion +0,96 %
6 Spineway Act Hauptdiskussion -30,30 %
7 Luxxfolio Holdings Inc Bitcoin Mining +82,43 %
8 Trading- und Aktien-Chat
9 für alle, die es ehrlich meinen beim Traden.
10 MicroStrategy -0,88 %
Alle Diskussionen
Aktien
Thema
1 ATOS Hauptdiskussion -42,70 %
2 Europlasma Hauptdiskussion -43,52 %
3 HUGO BOSS Hauptdiskussion -8,48 %
4 TUI Hauptforum +2,02 %
5 GAMESTOP Hauptdiskussion +0,71 %
6 Spineway Act Hauptdiskussion -29,25 %
7 Luxxfolio Holdings Inc Bitcoin Mining +110,81 %
8 MicroStrategy -0,88 %
9 VW Hauptdiskussion +0,15 %
10 NEL ohne Spam -5,71 %
Alle Diskussionen